Q4 2021 Holdings
Filed 2022-02-14 | 22 holdings | $18.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biothereapeutics(ARQT) | Common Stock | 03969K108 | $12.9M | 623,836 | 71.0% |
| Adagio Therapeutics(IVVD) | Common Stock | 00534A102 | $4.6M | 632,855 | 25.2% |
| Nuvation Bio(NUVB) | Class A Common Stock | 67080N101 | $195.1K | 22,957,340 | 1.1% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $129.1K | 4,763,380 | 0.7% |
| Imago Biosciences | Common Stock | 45250K107 | $71.6K | 3,018,737 | 0.4% |
| Morphic Holding | Common Stock | 61775R105 | $56.9K | 1,200,014 | 0.3% |
| Kronos Bio(KRON1USD) | Common Stock | 50107A104 | $51.9K | 3,818,283 | 0.3% |
| Gossamer Bio(GOSS) | Common Stock | 38341P102 | $35.8K | 3,164,835 | 0.2% |
| Ikena Oncology | Common Stock | 45175G108 | $28.2K | 2,249,123 | 0.2% |
| Alpine Immune Sciences(NVLSEUR) | Common Stock | 02083G100 | $28.1K | 2,029,580 | 0.2% |
| Immunic Inc(IMUX) | Common Stock | 4525EP101 | $17.1K | 1,788,160 | 0.1% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $13.1K | 843,750 | 0.1% |
| Icosavax | Common Stock | 45114M109 | $9.8K | 426,395 | 0.1% |
| Spruce Biosciences | Common Stock | 85209E109 | $9.6K | 2,161,022 | 0.1% |
| Theseus Pharmaceuticals | Common Stock | 88369M101 | $9.0K | 711,479 | 0.0% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $8.9K | 1,971,241 | 0.0% |
| Syros Pharmaceuticals | Common Stock | 87184Q107 | $8.2K | 2,512,705 | 0.0% |
| Omega Alpha Spac | Class A Common Stock | G6749V107 | $4.9K | 501,000 | 0.0% |
| Essa Pharma(EPIEUR) | Common Stock | 29668H708 | $4.7K | 328,196 | 0.0% |
| Checkmate Pharmaceuticals | Common Stock | 162818108 | $3.8K | 1,335,050 | 0.0% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $2.3K | 275,513 | 0.0% |
| Immunocore Holdings(IMCR) | Common Stock | 45258D105 | $1.8K | 51,535 | 0.0% |